The FDA has announced that the distribution of the Johnson & Johnson COVID-19 will be paused after six women in the U.S. had rare blood-clotting after receiving the vaccine. The women were ranging in ages from 18 to 48, and while six people may not seem like a lot precautions are being taken swiftly. There have been approximately 6.8 million shots given with the majority of people not having issues.
The pausing of the Johnson & Johnson vaccine does not affect the other two vaccines from Pfizer and Moderna. But if you did receive the Johnson & Johnson shot and are having to severe stomach pain, leg cramps, or severe headaches you should call your healthcare provider right away. If you do not know what shot you received, check your CDC vaccination card where it is noted what brand shot you received. If you have an appointment scheduled to receive the Johnson & Johnson COVID-19 vaccine, it is advised to call your provider for further directions.
Get Breaking News & Exclusive Contest in Your Inbox:
The Latest:
- Reflecting on My Experience Honoring Sandra Crouch | Ericaism
- Jason Kelce Lost His Super Bowl Ring in a Pool of Chili
- Sarah Jakes Roberts Talks Empowering Women and New Book
- Think And Grow Richer And Richer | Dr. Willie Jolley
- 2024 Tribeca Festival Boasts Diverse Lineup Of Promising Films
- Erica Campbell and Pastor Aventer Gray Announce Relish Conference 2024
- Atlantic City Mayor Marty Small’s Wife Charged with Endangering Welfare of Teen Daughter.
- Think Your Way To Success | Dr. Willie Jolley
- What Happened To Sade Robinson? Everything We Know About Her Mysterious Disappearance
- Gaza Protesters Shut Down Golden Gate Bridge In Day Of Action
FDA is Recommending Pausing the Use of Johnson and Johnson Vaccine in the U.S. was originally published on mycolumbusmagic.com